Defective tumor necrosis factor-α-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease

Daniela Rossi, Liliana Brambilla, Chiara F. Valori, Andrea Crugnola, Giorgio Giaccone, Raffaella Capobianco, Michela Mangieri, Ann E. Kingston, Alain Bloc, Paola Bezzi, Andrea Volterra

Research output: Contribution to journalArticle

Abstract

The cytokine tumor necrosis factor-α (TNFα) induces Ca 2+-dependent glutamate release from astrocytes via the downstream action of prostaglandin (PG) E 2. By this process, astrocytes may participate in intercellular communication and neuromodulation. Acute inflammation in vitro, induced by adding reactive microglia to astrocyte cultures, enhances TNFα production and amplifies glutamate release, switching the pathway into a neurodamaging cascade (Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., and Volterra, A. (2001) Nat. Neurosci. 4, 702-710). Because glial inflammation is a component of Alzheimer disease (AD) and TNFα is overexpressed in AD brains, we investigated possible alterations of the cytokine-dependent pathway in PDAPP mice, a transgenic model of AD. Glutamate release was measured in acute hippocampal and cerebellar slices from mice at early (4-month-old) and late (12-month-old) disease stages in comparison with age-matched controls. Surprisingly, TNFα-evoked glutamate release, normal in 4-month-old PDAPP mice, was dramatically reduced in the hippocampus of 12-month-old animals. This defect correlated with the presence of numerous β-amyloid deposits and hypertrophic astrocytes. In contrast, release was normal in cerebellum, a region devoid of β-amyloid deposition and astrocytosis. The Ca 2+-dependent process by which TNFα evokes glutamate release in acute slices is distinct from synaptic release and displays properties identical to those observed in cultured astrocytes, notably PG dependence. However, prostaglandin E 2 induced normal glutamate release responses in 12-month-old PDAPP mice, suggesting that the pathology-associated defect involves the TNFα-dependent control of secretion rather than the secretory process itself. Reduced expression of DENN/MADD, a mediator of TNFα-PG coupling, might account for the defect. Alteration of this neuromodulatory astrocytic pathway is described here for the first time in relation to Alzheimer disease.

Original languageEnglish
Pages (from-to)42088-42096
Number of pages9
JournalJournal of Biological Chemistry
Volume280
Issue number51
DOIs
Publication statusPublished - Dec 23 2005

Fingerprint

Astrocytes
Transgenic Mice
Glutamic Acid
Alzheimer Disease
Tumor Necrosis Factor-alpha
Prostaglandins E
Amyloid
Defects
Prostaglandins
Cytokines
Inflammation
Gliosis
Secretory Pathway
Amyloid Plaques
Microglia
Pathology
Neuroglia
Cerebellum
Hippocampus
Brain

ASJC Scopus subject areas

  • Biochemistry

Cite this

Defective tumor necrosis factor-α-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. / Rossi, Daniela; Brambilla, Liliana; Valori, Chiara F.; Crugnola, Andrea; Giaccone, Giorgio; Capobianco, Raffaella; Mangieri, Michela; Kingston, Ann E.; Bloc, Alain; Bezzi, Paola; Volterra, Andrea.

In: Journal of Biological Chemistry, Vol. 280, No. 51, 23.12.2005, p. 42088-42096.

Research output: Contribution to journalArticle

Rossi, Daniela ; Brambilla, Liliana ; Valori, Chiara F. ; Crugnola, Andrea ; Giaccone, Giorgio ; Capobianco, Raffaella ; Mangieri, Michela ; Kingston, Ann E. ; Bloc, Alain ; Bezzi, Paola ; Volterra, Andrea. / Defective tumor necrosis factor-α-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 51. pp. 42088-42096.
@article{46646c4041454e67908a74569495dd3e,
title = "Defective tumor necrosis factor-α-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease",
abstract = "The cytokine tumor necrosis factor-α (TNFα) induces Ca 2+-dependent glutamate release from astrocytes via the downstream action of prostaglandin (PG) E 2. By this process, astrocytes may participate in intercellular communication and neuromodulation. Acute inflammation in vitro, induced by adding reactive microglia to astrocyte cultures, enhances TNFα production and amplifies glutamate release, switching the pathway into a neurodamaging cascade (Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., and Volterra, A. (2001) Nat. Neurosci. 4, 702-710). Because glial inflammation is a component of Alzheimer disease (AD) and TNFα is overexpressed in AD brains, we investigated possible alterations of the cytokine-dependent pathway in PDAPP mice, a transgenic model of AD. Glutamate release was measured in acute hippocampal and cerebellar slices from mice at early (4-month-old) and late (12-month-old) disease stages in comparison with age-matched controls. Surprisingly, TNFα-evoked glutamate release, normal in 4-month-old PDAPP mice, was dramatically reduced in the hippocampus of 12-month-old animals. This defect correlated with the presence of numerous β-amyloid deposits and hypertrophic astrocytes. In contrast, release was normal in cerebellum, a region devoid of β-amyloid deposition and astrocytosis. The Ca 2+-dependent process by which TNFα evokes glutamate release in acute slices is distinct from synaptic release and displays properties identical to those observed in cultured astrocytes, notably PG dependence. However, prostaglandin E 2 induced normal glutamate release responses in 12-month-old PDAPP mice, suggesting that the pathology-associated defect involves the TNFα-dependent control of secretion rather than the secretory process itself. Reduced expression of DENN/MADD, a mediator of TNFα-PG coupling, might account for the defect. Alteration of this neuromodulatory astrocytic pathway is described here for the first time in relation to Alzheimer disease.",
author = "Daniela Rossi and Liliana Brambilla and Valori, {Chiara F.} and Andrea Crugnola and Giorgio Giaccone and Raffaella Capobianco and Michela Mangieri and Kingston, {Ann E.} and Alain Bloc and Paola Bezzi and Andrea Volterra",
year = "2005",
month = "12",
day = "23",
doi = "10.1074/jbc.M504124200",
language = "English",
volume = "280",
pages = "42088--42096",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "51",

}

TY - JOUR

T1 - Defective tumor necrosis factor-α-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease

AU - Rossi, Daniela

AU - Brambilla, Liliana

AU - Valori, Chiara F.

AU - Crugnola, Andrea

AU - Giaccone, Giorgio

AU - Capobianco, Raffaella

AU - Mangieri, Michela

AU - Kingston, Ann E.

AU - Bloc, Alain

AU - Bezzi, Paola

AU - Volterra, Andrea

PY - 2005/12/23

Y1 - 2005/12/23

N2 - The cytokine tumor necrosis factor-α (TNFα) induces Ca 2+-dependent glutamate release from astrocytes via the downstream action of prostaglandin (PG) E 2. By this process, astrocytes may participate in intercellular communication and neuromodulation. Acute inflammation in vitro, induced by adding reactive microglia to astrocyte cultures, enhances TNFα production and amplifies glutamate release, switching the pathway into a neurodamaging cascade (Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., and Volterra, A. (2001) Nat. Neurosci. 4, 702-710). Because glial inflammation is a component of Alzheimer disease (AD) and TNFα is overexpressed in AD brains, we investigated possible alterations of the cytokine-dependent pathway in PDAPP mice, a transgenic model of AD. Glutamate release was measured in acute hippocampal and cerebellar slices from mice at early (4-month-old) and late (12-month-old) disease stages in comparison with age-matched controls. Surprisingly, TNFα-evoked glutamate release, normal in 4-month-old PDAPP mice, was dramatically reduced in the hippocampus of 12-month-old animals. This defect correlated with the presence of numerous β-amyloid deposits and hypertrophic astrocytes. In contrast, release was normal in cerebellum, a region devoid of β-amyloid deposition and astrocytosis. The Ca 2+-dependent process by which TNFα evokes glutamate release in acute slices is distinct from synaptic release and displays properties identical to those observed in cultured astrocytes, notably PG dependence. However, prostaglandin E 2 induced normal glutamate release responses in 12-month-old PDAPP mice, suggesting that the pathology-associated defect involves the TNFα-dependent control of secretion rather than the secretory process itself. Reduced expression of DENN/MADD, a mediator of TNFα-PG coupling, might account for the defect. Alteration of this neuromodulatory astrocytic pathway is described here for the first time in relation to Alzheimer disease.

AB - The cytokine tumor necrosis factor-α (TNFα) induces Ca 2+-dependent glutamate release from astrocytes via the downstream action of prostaglandin (PG) E 2. By this process, astrocytes may participate in intercellular communication and neuromodulation. Acute inflammation in vitro, induced by adding reactive microglia to astrocyte cultures, enhances TNFα production and amplifies glutamate release, switching the pathway into a neurodamaging cascade (Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., and Volterra, A. (2001) Nat. Neurosci. 4, 702-710). Because glial inflammation is a component of Alzheimer disease (AD) and TNFα is overexpressed in AD brains, we investigated possible alterations of the cytokine-dependent pathway in PDAPP mice, a transgenic model of AD. Glutamate release was measured in acute hippocampal and cerebellar slices from mice at early (4-month-old) and late (12-month-old) disease stages in comparison with age-matched controls. Surprisingly, TNFα-evoked glutamate release, normal in 4-month-old PDAPP mice, was dramatically reduced in the hippocampus of 12-month-old animals. This defect correlated with the presence of numerous β-amyloid deposits and hypertrophic astrocytes. In contrast, release was normal in cerebellum, a region devoid of β-amyloid deposition and astrocytosis. The Ca 2+-dependent process by which TNFα evokes glutamate release in acute slices is distinct from synaptic release and displays properties identical to those observed in cultured astrocytes, notably PG dependence. However, prostaglandin E 2 induced normal glutamate release responses in 12-month-old PDAPP mice, suggesting that the pathology-associated defect involves the TNFα-dependent control of secretion rather than the secretory process itself. Reduced expression of DENN/MADD, a mediator of TNFα-PG coupling, might account for the defect. Alteration of this neuromodulatory astrocytic pathway is described here for the first time in relation to Alzheimer disease.

UR - http://www.scopus.com/inward/record.url?scp=29644434681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29644434681&partnerID=8YFLogxK

U2 - 10.1074/jbc.M504124200

DO - 10.1074/jbc.M504124200

M3 - Article

C2 - 16253995

AN - SCOPUS:29644434681

VL - 280

SP - 42088

EP - 42096

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -